Topoisomerase I amplification in melanoma is associated with more advanced tumours and poor prognosis.
about
Identifying mRNA, microRNA and protein profiles of melanoma exosomesBioinformatic identification of proteins with tissue-specific expression for biomarker discoveryMechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort.Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer.Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer.Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development.
P2860
Topoisomerase I amplification in melanoma is associated with more advanced tumours and poor prognosis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Topoisomerase I amplification ...... ed tumours and poor prognosis.
@en
Topoisomerase I amplification ...... ed tumours and poor prognosis.
@nl
type
label
Topoisomerase I amplification ...... ed tumours and poor prognosis.
@en
Topoisomerase I amplification ...... ed tumours and poor prognosis.
@nl
prefLabel
Topoisomerase I amplification ...... ed tumours and poor prognosis.
@en
Topoisomerase I amplification ...... ed tumours and poor prognosis.
@nl
P2093
P2860
P50
P1476
Topoisomerase I amplification ...... ced tumours and poor prognosis
@en
P2093
Caroline Kampf
Denise Ryan
Gabriela Gremel
Mairin Rafferty
Margret Agnarsdottir
Michael Bergqvist
Peter A Dervan
Robert C Millikan
Sara Strömberg
Shauna Hegarty
P2860
P304
P356
10.1111/J.1755-148X.2010.00720.X
P577
2010-04-30T00:00:00Z